Board Moves.

‍2Seventy Bio (NASDAQ: TSVT)

Promotes William Baird to CEO and he is appointed to the Board of Directors.

AbbVie (NYSE: ABBV)

Promotes Robert Michael to CEO and he is appointed to the Board of Directors. Mr. Michael is the former President and COO at AbbVie.

Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Appoints Hongbo Lu to the Board of Directors. Ms. Lu is a former Managing Partner at Vivo.

AtriCure (NASDAQ: ATRC)

Appoints Shlomi Nachman to the Board of Directors. Ms. Nachman is the former Group Chairman at J&J.

Bausch Health Cos (NYSE: BHC)

Appoints Christian Garcia and Frank Lee to the Board of Directors. Mr. Garcia is the former CFO at BrandSafway Industries and Mr. Lee is the CEO at Pacira Biosciences.

Bicycle Therapeutics (NASDAQ: BCYC)

Appoints Stephen Sands to the Board of Directors. Mr. Sands is the former Chair of the Board at Lazard.

Coherus Biosciences (NASDAQ: CHRS)

Appoints Georgia Erbez to the Board of Directors. Ms. Erbez is a Managing Director at Axiom Financial Partners.

Gilead Sciences (NASDAQ: GILD)

Appoints Ted Love to the Board of Directors. Mr. Love is the Chair of the Board at Biotechnology Innovation Organization.

LivaNova plc (NASDAQ: LIVN)

Vladimir Makatsaria named CEO and he is appointed to the Board of Directors. Mr. Makatsaria is the former Chair, MedTech at J&J Group.

MSA Safety (NYSE: MSA)

Steven Blanco is promoted to CEO and he is appointed to the Board of Directors. Mr. Blanco is the former COO at MSA Safety.

National Vision (NASDAQ: EYE)

Appoints Susan O’Farrell to the Board of Directors. Ms. O’Farrell is the former CFO and CAO at BlueLinx.

Nevro (NYSE: NVRO)

Appoints Kirt Karros to the Board of Directors. Mr. Karros is the EVP of Finance & Treasurer at Hewlett Packard Enterprise.

‍Patterson Companies (NASDAQ: PDCO)

Appoints Pamela Tomczik to the Board of Directors. Ms. is the SVP, Treasurer & Corporate Development at Target.

Prothena (NASDAQ: PRTA)

Appoints Daniel Welch to the Board of Directors as the Chair of the Board. Mr. Welch is a former Executive Partner at Sofinnova Ventures.

Pulmonx (NASDAQ: LUNG)

Names Steven Williamson CEO and he is appointed to the Board of Directors. Mr. Williamson is the former Medical Chief Commercial Officerat Outset.

Spyre Therapeutics (NASDAQ: SYRE)

Appoints Mark McKenna to the Board of Directors. Mr. McKenna is the Chief Investment Officer at McKenna Capital.

Terns Pharmaceuticals (NASDAQ: TERN)

Amy Burroughs named CEO and she is appointed to the Board of Directors. Ms. Burroughs is the former CEO at Cleave Therapeutics.

Zymeworks (NASDAQ: ZYME)

Appoints Alessandra Cesano to the Board of Directors. Ms. Cesano is the former Chief Medical Officer at ESSA Pharma.

‍

‍AbCellera Biologics (NASDAQ: ABCL)

Peter Thiel retires from the Board of Directors. Mr. Thiel is a Technology Entrepreneur & Investor.

Aclaris Therapeutics (NASDAQ: ACRS)

Douglas Manion resigns as CEO and from the Board of Directors.

AMN Healthcare Srvs (NYSE: AMN)

Martha Marsh retires from the Board of Director. Ms. Marsh is the former CEO at Stanford Hospital and Clinics.

AngioDynamics (NASDAQ: ANGO)

Dennis Meteny retires from the Board of Directors. Mr. Meteny is the former President & CEO at Cygnus Manufacturing Company.

Anika Therapeutics (NASDAQ: ANIK)

Jeffery Thompson retires from the Board of Directors. Mr. Thompson is a Partner at HealthEdge Investment Partners.

Guardant Health (NASDAQ: GH)

Samir Kaul resigns from the Board of Directors. Mr. Kaul is a General Partner at Khosla Ventures.

Inari Medical (NASDAQ: NARI)

Kirk Nielsen resigns from the Board of Directors. Mr. Nielsen is a Managing Partner at Vensana Capital.

Invivyd (NASDAQ: IVVD)

Tom Heyman to leave the Board of Directors. Mr. Heyman is the former President of Development Corp at J&J.

Masimo (NASDAQ: MASI)

Adam Mikkelson resigns from the Board of Directors. Mr. Mikkelson is a Partner at Camber Capital Management.

Merck & Co (NYSE: MRK)

Peter Wendell retires from the Board of Directors. Mr. Wendell is a Managing Director at Sierra Ventures.